Your browser doesn't support javascript.
loading
Nonclinical Toxicology and Biocompatibility Program Supporting Clinical Development and Registration of the Port Delivery System With Ranibizumab for Neovascular Age-Related Macular Degeneration.
Bantseev, Vladimir; Horvath, Joshua; Barteselli, Giulio; Ranade, Shrirang; Maia, Mauricio; Yadav, Daniela Bumbaca; Schuetz, Chris; Shelton, Amy; Booler, Helen S.
Afiliação
  • Bantseev V; 7412Genentech, Inc, South San Francisco, CA, USA. Yadav is now with Merck, South San Francisco, CA, USA. Booler is now with Roche, Basel, Switzerland.
  • Horvath J; 7412Genentech, Inc, South San Francisco, CA, USA. Yadav is now with Merck, South San Francisco, CA, USA. Booler is now with Roche, Basel, Switzerland.
  • Barteselli G; 7412Genentech, Inc, South San Francisco, CA, USA. Yadav is now with Merck, South San Francisco, CA, USA. Booler is now with Roche, Basel, Switzerland.
  • Ranade S; 7412Genentech, Inc, South San Francisco, CA, USA. Yadav is now with Merck, South San Francisco, CA, USA. Booler is now with Roche, Basel, Switzerland.
  • Maia M; 7412Genentech, Inc, South San Francisco, CA, USA. Yadav is now with Merck, South San Francisco, CA, USA. Booler is now with Roche, Basel, Switzerland.
  • Yadav DB; 7412Genentech, Inc, South San Francisco, CA, USA. Yadav is now with Merck, South San Francisco, CA, USA. Booler is now with Roche, Basel, Switzerland.
  • Schuetz C; 7412Genentech, Inc, South San Francisco, CA, USA. Yadav is now with Merck, South San Francisco, CA, USA. Booler is now with Roche, Basel, Switzerland.
  • Shelton A; 7412Genentech, Inc, South San Francisco, CA, USA. Yadav is now with Merck, South San Francisco, CA, USA. Booler is now with Roche, Basel, Switzerland.
  • Booler HS; 7412Genentech, Inc, South San Francisco, CA, USA. Yadav is now with Merck, South San Francisco, CA, USA. Booler is now with Roche, Basel, Switzerland.
Toxicol Pathol ; 49(3): 663-672, 2021 04.
Article em En | MEDLINE | ID: mdl-33205714

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ranibizumab / Degeneração Macular Limite: Animals Idioma: En Revista: Toxicol Pathol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ranibizumab / Degeneração Macular Limite: Animals Idioma: En Revista: Toxicol Pathol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suíça